Deanna Langfitt

St. Jude Children's Research Hospital

*This is an algorithmically generated author record based on publicly available information.

See Latest Publications

See Most Cited Publications

ORCID Profile

Google Scholar

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

St. Jude Children's Research Hospital

Research Subjects

Immunology

Research Interests

Deanna Langfitt has a total of 191 co-authors. Here are the top co-authors by number of shared publications:

Giedre Krenciute
Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, TN, USA
36 shared publications
Peter Vogel
Department of Pathology, St. Jude Children’s Research Hospital, Memphis, TN 38105, USA
30 shared publications
Jorge Ibañez
Bone Marrow Transplantation and Cellular Therapy, St Jude Children’s Research Hospital, Memphis, Tennessee, USA
29 shared publications
Michaela M. Meehl
Department of Bone Marrow Transplantation and Cellular Therapy (BMTCT), St. Jude Children’s Research Hospital, Memphis, Tennessee
28 shared publications
Heather Sheppard
26 shared publications
Alisha Kardian
St. Jude Children’s Research Hospital Department of Developmental Neurobiology Memphis, Tennessee
25 shared publications

Latest Publications

Sort by

Open Access
Website
Google Scholar
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Figure S13 legend1 from B7-H3 CAR T Cells Are Effective against Ependymomas but Limited by Tumor Size and Immune Response
by Sanya Mehta, Siri Ippagunta, Srinidhi Varadharajan, Alisha Kardian, Nic Laboe, Diana Dinh, Amber B. Jones, Michaela M. Meehl, Jorge Ibañez, Erik Emanus, et al.
Figure S13 legend1 from B7-H3 CAR T Cells Are Effective against Ependymomas but Limited by Tumor Size and Immune Response
Website
Google Scholar
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Figure S13 legend1 from B7-H3 CAR T Cells Are Effective against Ependymomas but Limited by Tumor Size and Immune Response
by Sanya Mehta, Siri Ippagunta, Srinidhi Varadharajan, Alisha Kardian, Nic Laboe, Diana Dinh, Amber B. Jones, Michaela M. Meehl, Jorge Ibañez, Erik Emanus, et al.
Figure S13 legend1 from B7-H3 CAR T Cells Are Effective against Ependymomas but Limited by Tumor Size and Immune Response
Open Access
Website
Google Scholar
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Figure S4 from B7-H3 CAR T Cells Are Effective against Ependymomas but Limited by Tumor Size and Immune Response
by Sanya Mehta, Siri Ippagunta, Srinidhi Varadharajan, Alisha Kardian, Nic Laboe, Diana Dinh, Amber B. Jones, Michaela M. Meehl, Jorge Ibañez, Erik Emanus, et al.
Figure S4 shows antigen profiling of HER2 in ZFTA-fusion driven EPN cell lines.
Website
Google Scholar
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Figure S4 from B7-H3 CAR T Cells Are Effective against Ependymomas but Limited by Tumor Size and Immune Response
by Sanya Mehta, Siri Ippagunta, Srinidhi Varadharajan, Alisha Kardian, Nic Laboe, Diana Dinh, Amber B. Jones, Michaela M. Meehl, Jorge Ibañez, Erik Emanus, et al.
Figure S4 shows antigen profiling of HER2 in ZFTA-fusion driven EPN cell lines.
Open Access
Website
Google Scholar
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Figure S16 from B7-H3 CAR T Cells Are Effective against Ependymomas but Limited by Tumor Size and Immune Response
by Sanya Mehta, Siri Ippagunta, Srinidhi Varadharajan, Alisha Kardian, Nic Laboe, Diana Dinh, Amber B. Jones, Michaela M. Meehl, Jorge Ibañez, Erik Emanus, et al.
Figure S16 shows high potency but limited durability of B7-H3.CAR T-cells against ZFTA-RELA EPN xenograft tumors in vivo.
Website
Google Scholar
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Figure S16 from B7-H3 CAR T Cells Are Effective against Ependymomas but Limited by Tumor Size and Immune Response
by Sanya Mehta, Siri Ippagunta, Srinidhi Varadharajan, Alisha Kardian, Nic Laboe, Diana Dinh, Amber B. Jones, Michaela M. Meehl, Jorge Ibañez, Erik Emanus, et al.
Figure S16 shows high potency but limited durability of B7-H3.CAR T-cells against ZFTA-RELA EPN xenograft tumors in vivo.
Open Access
Website
Google Scholar
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Figure S20 from B7-H3 CAR T Cells Are Effective against Ependymomas but Limited by Tumor Size and Immune Response
by Sanya Mehta, Siri Ippagunta, Srinidhi Varadharajan, Alisha Kardian, Nic Laboe, Diana Dinh, Amber B. Jones, Michaela M. Meehl, Jorge Ibañez, Erik Emanus, et al.
Figure S20 shows in vitro efficacy of murine B7-H3.CAR T-cells against murine ZFTA-RELA EPN cell line.
Website
Google Scholar
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Figure S20 from B7-H3 CAR T Cells Are Effective against Ependymomas but Limited by Tumor Size and Immune Response
by Sanya Mehta, Siri Ippagunta, Srinidhi Varadharajan, Alisha Kardian, Nic Laboe, Diana Dinh, Amber B. Jones, Michaela M. Meehl, Jorge Ibañez, Erik Emanus, et al.
Figure S20 shows in vitro efficacy of murine B7-H3.CAR T-cells against murine ZFTA-RELA EPN cell line.
Open Access
Website
Google Scholar
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Figure S19 from B7-H3 CAR T Cells Are Effective against Ependymomas but Limited by Tumor Size and Immune Response
by Sanya Mehta, Siri Ippagunta, Srinidhi Varadharajan, Alisha Kardian, Nic Laboe, Diana Dinh, Amber B. Jones, Michaela M. Meehl, Jorge Ibañez, Erik Emanus, et al.
Figure S19 shows successful infiltration of HER2.CAR T-cells inside 1425 EPN xenograft tumors.
Website
Google Scholar
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Figure S19 from B7-H3 CAR T Cells Are Effective against Ependymomas but Limited by Tumor Size and Immune Response
by Sanya Mehta, Siri Ippagunta, Srinidhi Varadharajan, Alisha Kardian, Nic Laboe, Diana Dinh, Amber B. Jones, Michaela M. Meehl, Jorge Ibañez, Erik Emanus, et al.
Figure S19 shows successful infiltration of HER2.CAR T-cells inside 1425 EPN xenograft tumors.
Open Access
Website
Google Scholar
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Table S1 and S2 from B7-H3 CAR T Cells Are Effective against Ependymomas but Limited by Tumor Size and Immune Response
by Sanya Mehta, Siri Ippagunta, Srinidhi Varadharajan, Alisha Kardian, Nic Laboe, Diana Dinh, Amber B. Jones, Michaela M. Meehl, Jorge Ibañez, Erik Emanus, et al.
Supplementary Tables S1 and S2
Website
Google Scholar
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Table S1 and S2 from B7-H3 CAR T Cells Are Effective against Ependymomas but Limited by Tumor Size and Immune Response
by Sanya Mehta, Siri Ippagunta, Srinidhi Varadharajan, Alisha Kardian, Nic Laboe, Diana Dinh, Amber B. Jones, Michaela M. Meehl, Jorge Ibañez, Erik Emanus, et al.
Supplementary Tables S1 and S2
Open Access
Website
Google Scholar
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Figure S14 from B7-H3 CAR T Cells Are Effective against Ependymomas but Limited by Tumor Size and Immune Response
by Sanya Mehta, Siri Ippagunta, Srinidhi Varadharajan, Alisha Kardian, Nic Laboe, Diana Dinh, Amber B. Jones, Michaela M. Meehl, Jorge Ibañez, Erik Emanus, et al.
Figure S14 shows comparison of phenotypic characteristics between B7-H3.CAR and HER2.CAR T-cells during repeated stimulation with 1425 cell line.
Website
Google Scholar
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Figure S14 from B7-H3 CAR T Cells Are Effective against Ependymomas but Limited by Tumor Size and Immune Response
by Sanya Mehta, Siri Ippagunta, Srinidhi Varadharajan, Alisha Kardian, Nic Laboe, Diana Dinh, Amber B. Jones, Michaela M. Meehl, Jorge Ibañez, Erik Emanus, et al.
Figure S14 shows comparison of phenotypic characteristics between B7-H3.CAR and HER2.CAR T-cells during repeated stimulation with 1425 cell line.
Open Access
Website
Google Scholar
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Figure S15 from B7-H3 CAR T Cells Are Effective against Ependymomas but Limited by Tumor Size and Immune Response
by Sanya Mehta, Siri Ippagunta, Srinidhi Varadharajan, Alisha Kardian, Nic Laboe, Diana Dinh, Amber B. Jones, Michaela M. Meehl, Jorge Ibañez, Erik Emanus, et al.
Figure S15 shows increased inhibitory marker expression on B7-H3.CAR T-cells compared to HER2.CAR T-cells following repeated stimulation with 1425 cell line.
Website
Google Scholar
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Figure S15 from B7-H3 CAR T Cells Are Effective against Ependymomas but Limited by Tumor Size and Immune Response
by Sanya Mehta, Siri Ippagunta, Srinidhi Varadharajan, Alisha Kardian, Nic Laboe, Diana Dinh, Amber B. Jones, Michaela M. Meehl, Jorge Ibañez, Erik Emanus, et al.
Figure S15 shows increased inhibitory marker expression on B7-H3.CAR T-cells compared to HER2.CAR T-cells following repeated stimulation with 1425 cell line.
Open Access
Website
Google Scholar
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Figure S11 from B7-H3 CAR T Cells Are Effective against Ependymomas but Limited by Tumor Size and Immune Response
by Sanya Mehta, Siri Ippagunta, Srinidhi Varadharajan, Alisha Kardian, Nic Laboe, Diana Dinh, Amber B. Jones, Michaela M. Meehl, Jorge Ibañez, Erik Emanus, et al.
Figure S11 shows phenotypic characteristics of human HER2.CAR T-cells.
Website
Google Scholar
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Figure S11 from B7-H3 CAR T Cells Are Effective against Ependymomas but Limited by Tumor Size and Immune Response
by Sanya Mehta, Siri Ippagunta, Srinidhi Varadharajan, Alisha Kardian, Nic Laboe, Diana Dinh, Amber B. Jones, Michaela M. Meehl, Jorge Ibañez, Erik Emanus, et al.
Figure S11 shows phenotypic characteristics of human HER2.CAR T-cells.
Open Access
Website
Google Scholar
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Figure S7 from B7-H3 CAR T Cells Are Effective against Ependymomas but Limited by Tumor Size and Immune Response
by Sanya Mehta, Siri Ippagunta, Srinidhi Varadharajan, Alisha Kardian, Nic Laboe, Diana Dinh, Amber B. Jones, Michaela M. Meehl, Jorge Ibañez, Erik Emanus, et al.
Figure S7 shows inverse correlation between B7-H3.CAR T-cell expansion and B7-H3 target antigen density.
Website
Google Scholar
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Figure S7 from B7-H3 CAR T Cells Are Effective against Ependymomas but Limited by Tumor Size and Immune Response
by Sanya Mehta, Siri Ippagunta, Srinidhi Varadharajan, Alisha Kardian, Nic Laboe, Diana Dinh, Amber B. Jones, Michaela M. Meehl, Jorge Ibañez, Erik Emanus, et al.
Figure S7 shows inverse correlation between B7-H3.CAR T-cell expansion and B7-H3 target antigen density.

Show all